Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eldervit-12 is a multivitamin combination product containing folic acid, methylcobalamin (Vitamin B12), niacinamide (Vitamin B3), and ascorbic acid (Vitamin C). It is primarily indicated for the treatment of nutritional deficiencies, megaloblastic anemia, and peripheral neuropathy. The components function as essential cofactors in various metabolic pathways: folic acid and methylcobalamin are critical for DNA synthesis and red blood cell production, specifically involving enzymes like 5,10-methylenetetrahydrofolate reductase and methionine synthase. Niacinamide acts as a precursor to the coenzymes nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), which are vital for cellular respiration and energy metabolism. Ascorbic acid serves as a potent antioxidant that scavenges free radicals and is a necessary cofactor for collagen synthesis. Originally developed by Elder Pharmaceuticals, the brand was acquired by Torrent Pharmaceuticals for the Indian and Nepalese markets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Eldervit-12.